Cargando…
Gene therapy for spinal muscular atrophy: the benefit–cost profile
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343260/ https://www.ncbi.nlm.nih.gov/pubmed/34386755 http://dx.doi.org/10.1016/j.eclinm.2021.101065 |
| _version_ | 1783734247440252928 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8343260 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83432602021-08-11 Gene therapy for spinal muscular atrophy: the benefit–cost profile EClinicalMedicine Editorial Elsevier 2021-07-27 /pmc/articles/PMC8343260/ /pubmed/34386755 http://dx.doi.org/10.1016/j.eclinm.2021.101065 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Editorial Gene therapy for spinal muscular atrophy: the benefit–cost profile |
| title | Gene therapy for spinal muscular atrophy: the benefit–cost profile |
| title_full | Gene therapy for spinal muscular atrophy: the benefit–cost profile |
| title_fullStr | Gene therapy for spinal muscular atrophy: the benefit–cost profile |
| title_full_unstemmed | Gene therapy for spinal muscular atrophy: the benefit–cost profile |
| title_short | Gene therapy for spinal muscular atrophy: the benefit–cost profile |
| title_sort | gene therapy for spinal muscular atrophy: the benefit–cost profile |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343260/ https://www.ncbi.nlm.nih.gov/pubmed/34386755 http://dx.doi.org/10.1016/j.eclinm.2021.101065 |